Product Description
Product Name: Imatinib Tablets
Strength: 400 mg
Form: Oral Tablet
Category: Targeted Therapy / Tyrosine Kinase Inhibitor (TKI)
Indication: Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), Gastrointestinal Stromal Tumors (GIST), and Other Tyrosine Kinase-Driven Cancers
Imatinib 400 mg Tablets are a targeted anticancer therapy used in the treatment of various cancers, particularly those driven by specific genetic mutations. It is most commonly prescribed for chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), and gastrointestinal stromal tumors (GISTs).
